Results 141 to 150 of about 2,524 (195)

In response to the article «Reluctance of parents to immunize their children with nirsevimab»

Anales de Pediatría (English Edition)
David, Andina Martínez, Esther, Fernández Mozo, Rocio, Trincado Lamuño, Jose Antonio, Alonso-Cadenas   +3 more
openaire   +2 more sources

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network. [PDF]

Lancet Reg Health West Pac
Wadia U, Richmond PC, Britton PN, Carr J, Clark JE, Crawford NW, Hung TY, Marshall HS, Macartney KK, Wood NJ, McMullan BJ, Moore HC, Effler PV, Cheng AC, Blyth CC, PAEDS-FluCAN Network.   +15 more
europepmc   +1 more source

Maternal Immunization Against Respiratory Syncytial Virus: An Updated WAidid Consensus Document on Evidence, Implementation, and Public Health Priorities. [PDF]

Vaccines (Basel)
Esposito S, Riccò M, Abu-Raya B, Icardi G, Spoulou V, Greenberg D, Falup Pecurariu O, Hung IF, Osterhaus A, Sambri V, Principi N.   +10 more
europepmc   +1 more source

Nirsevimab in Infants: The Cost of Changing the Paradigm

Mathews Journal of Pediatrics
openaire   +1 more source

Analysis of the Economic and Public Health Impact of New Immunization Strategies in Infants Against Respiratory Syncytial Virus (RSV) in Colombia. [PDF]

Infect Dis Ther
Carrasquilla-Sotomayor M, Alvis-Zakzuk NJ, Coronell-Rodríguez W, Arias A, Moyano-Tamara L, Alvarado-Gonzalez JC, De la Hoz-Restrepo F, Alvis-Guzman N.   +7 more
europepmc   +1 more source

Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. [PDF]

Infect Dis Ther
Alharbi AS, Abu-Shraie N, Al Abdulkarim H, Alharbi IH, Averin A, Law AW, Mendes D, Quinn E, Zayed M, Behiry A, Haridy H, Mousa M.   +11 more
europepmc   +1 more source

Cell culture medium influences RSV G protein glycosylation and recognition by monoclonal antibodies. [PDF]

Virol J
Engling N, Knittler MC, Tagore R, Ludlow M, Osterhaus ADME, Rimmelzwaan GF, Meineke R.   +6 more
europepmc   +1 more source

Correction: Factors Associated With Newborn Nirsevimab Administration in Los Angeles County During the 2024 Respiratory Syncytial Virus Season. [PDF]

J Pediatric Infect Dis Soc
europepmc   +1 more source